This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
ABSTRACT
Researchers from multiple institutions conducted a retrospective cross-sectional study to examine the association between stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD) and bone mass. Children and adolescents aged 8–20 years who participated in the 2005–2010 National Health and Nutrition Examination Survey (NHANES) were eligible. The primary predictor was stimulant use, which was self-reported by NHANES participants ≥16 years old and reported by proxies for younger participants. Stimulant users were defined as those who reported use of amphetamine, methylphenidate, lisdexamfetamine, dextroamphetamine, or levoamphetamine. Duration of stimulant use was categorized as <3 months …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.